| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.1M | +1516.6% |
| Cost of Revenue | $1.2M | — |
| Gross Profit | -$134K | -300.1% |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $1.6M | +44.6% |
| Operating Income | -$1.7M | -60.6% |
| Net Income | -$9.0M | -394.5% |
| EPS (Basic) | -$0.09 | -400.0% |
| EPS (Diluted) | $0.04 | +33.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $6K | — |
| Inventory | $200K | +207.9% |
| Current Assets | $418K | -80.0% |
| Total Assets | $2.7M | -10.5% |
| Current Liabilities | $1.2M | +1.3% |
| Total Liabilities | $8.5M | +468.2% |
| Stockholders' Equity | -$5.8M | -472.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.5M | -151.5% |
| Capital Expenditures | $645K | +305.4% |
| Investing Cash Flow | $816K | +178.9% |
| Financing Cash Flow | $557K | +131.5% |
| Free Cash Flow | -$2.2M | -177.3% |